Director's dealings

Archive 2012

Directors' Dealings

Pursuant to § 15a German Securities Trading Act (WpHG), members of the management board and supervisory board of Biotest AG, as well as any other persons performing executive functions with Biotest AG, are obliged to notify Biotest AG and the German Federal Financial Supervisory Authority (BaFin) of own transactions in Biotest shares, or financial instruments based on them. The notification duty also applies to individuals and legal entities closely associated with such persons.

Biotest AG will disclose details of any such transactions on this website without undue delay and will transmit to the German Federal Financial Supervisory Authority evidence of such disclosure.

Directors' Dealings in accordance with §15a WpHG
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
Nov 23, 2012 Purchase Xetra 46.9609 EUR 1288 60485.63
 Details of person:
Name/Company Reason Relationship
OGEL GmbH Legal person, company or institution closely associated To a person performing managerial responsibilities
 Basic data:
Description of financial instrument: Ordinary Shares
ISIN DE0005227201
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 

 
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
Nov 16, 2012 Purchase Xetra 46.962 EUR 3000 140886.00
 Details of person:
Name/Company Reason Relationship
OGEL GmbH Legal person, company or institution closely associated To a person performing managerial responsibilities
 Basic data:
Description of financial instrument: Ordinary Shares
ISIN DE0005227201
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 

 
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
Aug 17, 2012 Purchase außerbörslich 41.8317 EUR 2843 118927.52
 Details of person:
Name/Company Reason Relationship
OGEL GmbH Legal person, company or institution closely associated To a person performing managerial responsibilities
 Basic data:
Description of financial instrument: Ordinary Shares
ISIN DE0005227201
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 

 
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
Jun 05, 2012 Purchase Xetra 37.50 EUR 300 11250.00
 Details of person:
Name/Company Reason Position
Martin Dr. Reinecke
Biotest AG
Person performing managerial responsibilities Seniour Vice President Plasma Alliances and Protein Supply
 Basic data:
Description of financial instrument: Preference Shares
ISIN DE0005227235
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 

 
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
May 11, 2012 Purchase außerbörslich 40.36 EUR 500 20180.00
 Details of person:
Name/Company Reason Position
Michael Dr. Ramroth
Biotest AG
Person performing managerial responsibilities Member of a managing body
 Basic data:
Description of financial instrument: Preference Shares
ISIN DE0005227235
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland